Injections of semaglutide were associated with significant improvement in cognitive function in people living with HIV (PWH), ...

In January, the White House ordered an immediate halt to the distribution of HIV medications by U.S.-funded foreign clinics, ...

Cipla has announced an exclusive licensing agreement with Taiwan-based Formosa Pharmaceuticals to market clobetasol ...

The HIV Drugs Market is expected to grow steadily from 2025 to 2035, driven by advancements in antiretroviral therapy and increasing global awareness initiatives. Rising HIV prevalence, improved ...

This partnership aims to enhance ophthalmic care by providing better treatment for post-operative inflammation and pain in patients across 11 countries.

Data from two studies suggest that a once-daily combination therapy of doravirine and islatravir was noninferior to current, ...

Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...

A study shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States Food and Drug ...

"Discover the latest breakthrough in HIV prevention with Gilead's lenacapavir - a single injection providing yearlong ...

The global HIV drugs industry was valued at USD 28.6 billion in 2023 and is projected to grow at a CAGR of 4.7% from 2024 to ...

North America was the major shareholder in 2022. However, Asia-Pacific is expected to witness the highest CAGR during the forecast period. PO ...

India's largest drugmaker Sun Pharmaceutical Industries Ltd and its peers Cipla Ltd., Glenmark ... and psychotropic drugs, as well as anti-retroviral drugs (including HIV-treating medicines).